(Z)-3,5,4′-Tri-O-methyl-resveratrol, induces apoptosis in human lymphoblastoid cells independently of their p53 status

Cancer Letters

Volumn 211, Issue 2, 2004, Pages 155-161

  Schneider, Yann ^a   Fischer, Barbara ^a   Coelho, David ^a   Roussi, Stamatiki ^a   Gosse, Francine ^a   Bischoff, Pierre ^a   Raul, Francis ^a  

^a IRCAD   (France)

Author keywords

Cell cycle; Cytotoxicity; Lymphoblastoma; Polyphenol; Resveratrol

Indexed keywords

3,5,4' TRI O METHYLRESVERATROL; ANTINEOPLASTIC AGENT; CASPASE 3; PROTEIN P53; RESVERATROL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KNOCKOUT GENE; LYMPHOBLASTOID CELL; METAPHASE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANISOLES; APOPTOSIS; CASPASE 3; CASPASES; CELL CULTURE TECHNIQUES; CELL CYCLE; GENES, P53; GENETIC ENGINEERING; HUMANS; LEUKEMIA, LYMPHOCYTIC; STILBENES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042611728     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.02.017     Document Type: Article

References (27)

1. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come and gone. Clin. Biochem. 30:1997;91-113
2. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., Merillon J.M. Comparative study of radical scavenger and antioxydant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 61:1997;2103-2110
3. Chanvitayapongs S., Draczynska-Lusiak B., Sun A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport. 8:1997;499-1502
4. Pace-Asciak C.R., Hanh S., Diamandis E.P., Soleas G., Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta. 235:1995;207-219
5. Bertelli A.A., Giovannini L., Giannessi D., Migliori M., Bernini W., Fregoni M., Bertelli A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tissue React. 17:1995;1-3
6. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220
7. Schneider Y., Duranton B., Gossé F., Schleiffer R., Seiler N., Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr. Cancer. 39:2001;102-107
8. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann. NY Acad. Sci. 957:2002;210-229
9. Schneider Y., Chabert P., Stutzmann J., Coelho D., Fougerousse A., Gossé F., et al. Resveratrol analog (Z)-3, 5, 4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int. J. Cancer. 107:2003;189-196
10. Srivastava R.K., Srivastava A.R., Korsmeyer S.J., Nesterova M., Cho-Chung Y.S., Longo D.L. Involvement of microtubules in the regulation of Bcl-2 phosphorylation and apoptosis through cyclic AMP-dependant protein kinase. Mol. Cell Biol. 8:1998;3509-3517
11. Sorger P.K., Dobles M., Tournebize R., Hyman A.A. Coupling cell division and cell death to microtubule dynamics. Curr. Opin. Cell Biol. 9:1997;807-814
12. Fan W. Possible mechanisms of paclitaxel-induced apoptosis. Biochem. Pharmacol. 57:1999;1215-1221
13. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967
14. Merritt A.J., Potten C.S., Kemp C.J., Hickman J.A., Balmain A., Lane D.P., Hall P.A. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54:1994;614-617
15. Zhen W., Denault C.M., Loviscek K., Walter S., Geng L., Vaughan T.M. The relative radiosensitivity of TK6 and WI-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status. Mutat. Res. 346:1995;85-92
16. Wang L.G., Liu X.M., Kreis W., Budman D.R. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother. Pharmacol. 44:1999;355-361
17. Sablina A.A., Chumakov P.M., Levine A.J., Kopnin B.P. p53 activation in response to microtubule disruption is mediated by integrin-Erk signalling. Oncogene. 20:2001;899-909
18. Galmarini C.M., Falette N., Tabone E., Levrat C., Britten R., Voorzanger-Rousselot N., et al. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity. Br. J. Cancer. 85:2001;902-908
19. Chuang Y.-Y.E., Chen Q., Liber H.L. Radiation-induced mutations at the autosomal thymidine kinase locus are not elevated in p53-null cells. Cancer Res. 59:1999;3073-3076
20. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279
21. Gurtu V., Kain S.R., Zhang G. Fluorometric and colorimetric detection of Caspase activity associated with apoptosis. Anal. Biochem. 251:1997;98-102
22. Dorrie J., Gerauer H., Wachter Y., Zunino S.J. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 61:2001;4731-4739
23. Clement M.V., Hirpara J.L., Chawdhury S.H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signalling-dependent apoptosis in human tumor cells. Blood. 92:1998;996-1002
24. Hendrikse A.S., Hunter A.J., Keraan M., Blekkenhorst G.H. Effects of low dose irradiation on TK6 and U937 cells: induction of p53 and its role in cell-cycle delay and the adaptive response. Int. J. Radiat. Biol. 76:(1):2000;11-21
25. Mahyar-Roemer M., Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene. 20:2001;3387-3398
26. Spencer C.M., Faulds D. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs. 48:1994;794-847
27. Casenghi M., Mangiacasale R., Tuynder M., Caillet-Fauquet P., Elhajouji A., Lavia P., et al. p53-independent apoptosis and p53-dependent block of DNA replication following mitotic spindle inhibition in human cells. Exp. Cell Res. 250:1999;339-350